Skip to main content

Advertisement

Log in

Limited added value of whole spine MRI in spondyloarthritis for disease activity assessment

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

To evaluate the added value of whole spine magnetic resonance imaging (MRI) for disease activity assessment in ankylosing spondylitis (AS) and psoriatic arthritis (PsA).

Method

Spine and sacroiliac joint (SIJ) MRI scans requested by rheumatologists between 2012 and 2018 were screened retrospectively, and patients who had known diagnosis of AS or PsA were included, if the MRI was done for disease activity assessment. All MRI scans were reviewed by two experienced musculoskeletal radiologists independently, blinded to patients’ diagnosis and to the other MRI. Comparisons were done for the presence of active and structural lesions. In addition, radiologists were asked to rate for “confidence level for active inflammation related to SpA.” Analysis was done using the consensus scores.

Results

Ninety patients with known diagnosis of AS (n = 55) or PsA (n = 35) were included. The frequency of active and structural lesions was not significantly different both in AS vs PsA, neither in the cervical/thoracic/lumbar spine or the SIJ. The percentage of people only with any inflammatory changes on the spine MRI without any inflammation in the SIJ MRI was 24% in AS and 23% in PsA. However, considering the confidence level of the radiologists on active inflammation, only one patient’s spine MRI was scored as active, while SIJ MRI being negative for inflammation.

Conclusions

The spinal MRI had limited added value to the SIJ MRI in SpA, when performed to assess disease activity, limiting its value in routine practice unless clinically indicated.

Key Points

Spine MRI adds limited value to SIJs in SpA, when performed for disease activity assessment.

SpA disease activity assessment may be restricted to sacroiliac joint MRI, unless clinically indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377:2127–2137

    Article  Google Scholar 

  2. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT (1993) Differences in the expression of spondyloarthropathy: A comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med 16:1–7

    CAS  PubMed  Google Scholar 

  3. Gladman DD (2006) Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? Ann Rheum Dis 65(Suppl 3):iii22–iii24

    PubMed  PubMed Central  Google Scholar 

  4. Jadon DR, Sengupta R, Nightingale A, Lindsay M, Korendowych E, Robinson G et al (2017) Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis 76:701–707

    Article  Google Scholar 

  5. Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J (2008) Mri in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 67:1276–1281

    Article  CAS  Google Scholar 

  6. Braun J, Landewe R, Hermann KG, Han J, Yan S, Williamson P et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 54:1646–1652

    Article  CAS  Google Scholar 

  7. Hermann KG, Baraliakos X, van der Heijde DM, Jurik AG, Landewe R, Marzo-Ortega H et al (2012) Descriptions of spinal mri lesions and definition of a positive mri of the spine in axial spondyloarthritis: a consensual approach by the asas/omeract mri study group. Ann Rheum Dis 71:1278–1288

    Article  Google Scholar 

  8. Azmat O, Lambert RG, Jibri Z, Maksymowych WP (2017) Subchondral bone sclerosis on computed tomography – does it have any value in the diagnosis of inflammatory sacroiliitis or is it a non-specific finding? Ann Rheum Dis 76:668

  9. Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG et al (2016) Defining active sacroiliitis on mri for classification of axial spondyloarthritis: update by the asas mri working group. Ann Rheum Dis 75:1958–1963

    Article  Google Scholar 

  10. Salvarani C, Macchioni P, Cremonesi T, Mantovani W, Battistel B, Rossi F et al (1992) The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis 51:73–77

    Article  CAS  Google Scholar 

  11. Queiro R, Sarasqueta C, Torre JC, Tinture T, Lopez-Lagunas I (2002) Prevalence and predictors of cervical involvement in psoriatic spondyloarthropathy. J Clin Rheumatol 8:23–29

    Article  Google Scholar 

  12. Arslan Alhussain F, Kasapoglu Gunal E, Kurum E, Bakirci S, Ozturk AB, McGonagle D et al (2019) Greater magnitude of entheseal microdamage and repair in psoriatic arthritis compared with ankylosing spondylitis on ultrasound. Rheumatology (Oxford) 58:299–303

    Google Scholar 

  13. Solmaz D, Bakirci S, Jibri Z, Sampaio M, Karsh J, Aydin SZ (2020) Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis. Semin Arthritis Rheum 50:42–47

    Article  Google Scholar 

  14. Turkiewicz AM, Moreland LW (2007) Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 56:1051–1066

    Article  CAS  Google Scholar 

  15. Jadon DR, Nightingale AL, McHugh NJ, Lindsay MA, Korendowych E, Sengupta R (2015) Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol 42:21–30

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ummugulsum Gazel.

Ethics declarations

Disclosures

Sibel Zehra Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, Pfizer, and Sanofi. The other authors have disclosed no conflicts of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 37 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gazel, U., Ayan, G., Solmaz, D. et al. Limited added value of whole spine MRI in spondyloarthritis for disease activity assessment. Clin Rheumatol 40, 4909–4913 (2021). https://doi.org/10.1007/s10067-021-05837-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05837-x

Keywords

Navigation